CPL Biologicals
CPLBIO is a leading biotechnology company committed to research, development, and sustainability. It specializes in pharmaceuticals, agriculture, industrial biotechnology, and environmental solutions, aiming to create innovative, affordable solutions for global health challenges. The company invests heavily in R&D, collaborates with academic and industry partners, and emphasizes sustainability and quality in its operations.
Industries
Nr. of Employees
medium (51-250)
Products
VLP-based seasonal influenza vaccine (commercial launch)
A commercially launched seasonal influenza vaccine based on virus-like particle technology (reported as the company's VLP seasonal influenza product).
Vaccines (portfolio)
Development and commercialization of vaccines across priority indications with R&D through commercial manufacturing capabilities.
Biologics (proteins and therapeutic candidates)
Development and manufacture of biologic products, including proteins expressed and purified from multiple platforms for therapeutic or diagnostic use.
Diagnostic kits (ELISA and rapid tests)
Commercial immunoassay kits and rapid diagnostic test products for infectious disease detection and immune diagnostics.
VLP-based seasonal influenza vaccine (commercial launch)
A commercially launched seasonal influenza vaccine based on virus-like particle technology (reported as the company's VLP seasonal influenza product).
Vaccines (portfolio)
Development and commercialization of vaccines across priority indications with R&D through commercial manufacturing capabilities.
Biologics (proteins and therapeutic candidates)
Development and manufacture of biologic products, including proteins expressed and purified from multiple platforms for therapeutic or diagnostic use.
Diagnostic kits (ELISA and rapid tests)
Commercial immunoassay kits and rapid diagnostic test products for infectious disease detection and immune diagnostics.
Services
cGMP bulk biologics and vaccine manufacturing
Bulk upstream and downstream manufacturing across microbial, mammalian and insect platforms with chromatography and TFF downstream; modular single-use facility design and segregated processing areas.
Formulation, automated fill–finish and packaging
Automated formulation and aseptic fill–finish operations for vials and prefilled syringes with in-line inspection and high annual throughput capacities.
Process development, scale-up and technology transfer
End-to-end process development from proof-of-concept to scale-up, including formal technology transfer and facility start-up support for greenfield/brownfield projects.
Analytical assay and method development
Development and validation of analytical assays to support product characterization, QC release and stability testing for vaccines, biologics and diagnostics.
Diagnostic kit design and manufacture
Design and production of immunodiagnostic kits including ELISA and rapid lateral-flow / flow-through formats.
Regulatory audit and product registration support
Support for regulatory audits, documentation and activities required for product registration and compliance with global regulatory expectations.
cGMP bulk biologics and vaccine manufacturing
Bulk upstream and downstream manufacturing across microbial, mammalian and insect platforms with chromatography and TFF downstream; modular single-use facility design and segregated processing areas.
Formulation, automated fill–finish and packaging
Automated formulation and aseptic fill–finish operations for vials and prefilled syringes with in-line inspection and high annual throughput capacities.
Process development, scale-up and technology transfer
End-to-end process development from proof-of-concept to scale-up, including formal technology transfer and facility start-up support for greenfield/brownfield projects.
Analytical assay and method development
Development and validation of analytical assays to support product characterization, QC release and stability testing for vaccines, biologics and diagnostics.
Diagnostic kit design and manufacture
Design and production of immunodiagnostic kits including ELISA and rapid lateral-flow / flow-through formats.
Regulatory audit and product registration support
Support for regulatory audits, documentation and activities required for product registration and compliance with global regulatory expectations.
Expertise Areas
- Vaccine development
- Biologics process development and manufacturing
- Diagnostic kit development and manufacture
- Protein purification and downstream processing
Key Technologies
- Virus-like particle (VLP) technology
- Baculovirus–insect cell expression
- Microbial fermentation
- Mammalian cell culture